Dr. Eric Bernicker, MD
Claim this profileHouston Methodist Hospital
Area of expertise
Lung Cancer
Eric Bernicker, MD has run 4 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Eric Bernicker, MD has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Houston Methodist Hospital
Methodist Willowbrook Hospital
Clinical Trials Eric Bernicker, MD is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Eric Bernicker, MD
Clinical Trial Related
11 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Eric Bernicker, MD has experience with
- Atezolizumab
- Biospecimen Collection
- Crizotinib
- Carboplatin
- Gemcitabine Hydrochloride
- Paclitaxel
Breakdown of trials Eric Bernicker, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Bernicker, MD specialize in?
Eric Bernicker, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Eric Bernicker, MD currently recruiting for clinical trials?
Yes, Eric Bernicker, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eric Bernicker, MD has studied deeply?
Yes, Eric Bernicker, MD has studied treatments such as Atezolizumab, Biospecimen Collection, Crizotinib.
What is the best way to schedule an appointment with Eric Bernicker, MD?
Apply for one of the trials that Eric Bernicker, MD is conducting.
What is the office address of Eric Bernicker, MD?
The office of Eric Bernicker, MD is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.